Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04756401
What this trial is testing

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Academic and Community Cancer Research United 8
Early research (Phase 1)UnknownNCT05325801
What this trial is testing

CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zhejiang University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217119
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Looking for participantsNCT05896228
What this trial is testing

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaRelapsed Multiple Myeloma
Benjamin T Diamond, MD 30
Not applicableLooking for participantsNCT05956457
What this trial is testing

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed Hematologic Malignancy
Pack Health 100
Large-scale testing (Phase 3)Looking for participantsNCT05020236
What this trial is testing

Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Who this might be right for
Multiple Myeloma
Pfizer 893
Early research (Phase 1)UnknownNCT03674463
What this trial is testing

LCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Second Affiliated Hospital of Xi'an Jiaotong University 10
Early research (Phase 1)Looking for participantsNCT05363111
What this trial is testing

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00368121
What this trial is testing

EMMA-1 (Erbitux for Multiple Myeloma)

Who this might be right for
Multiple Myeloma
Prof. Dr. Andreas Engert 13
Early research (Phase 1)Looking for participantsNCT05976555
What this trial is testing

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 30
Early research (Phase 1)Looking for participantsNCT05651932
What this trial is testing

An MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaMyeloma Multiple
K36 Therapeutics, Inc. 165
Early research (Phase 1)Study completedNCT01497093
What this trial is testing

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 34
Testing effectiveness (Phase 2)Study completedNCT00022607
What this trial is testing

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
California Cancer Consortium
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT00378209
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 65
Large-scale testing (Phase 3)Looking for participantsNCT07623798
What this trial is testing

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd. 255
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Large-scale testing (Phase 3)Study completedNCT03029234
What this trial is testing

Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Amgen 126
Next Page